CL2009001087A1 - Mezcla de hidratos de carbono para su utilizacion en un producto alimenticio destinado a la nutricion enteral u oral que comprende almidon resistente de tipo iv, maltodextrina de baja dextrosa equivalente de=5-8, inulina y celulosa; producto alimenticio que la contiene; y uso de la mezcla de hidratos de carbono. - Google Patents

Mezcla de hidratos de carbono para su utilizacion en un producto alimenticio destinado a la nutricion enteral u oral que comprende almidon resistente de tipo iv, maltodextrina de baja dextrosa equivalente de=5-8, inulina y celulosa; producto alimenticio que la contiene; y uso de la mezcla de hidratos de carbono.

Info

Publication number
CL2009001087A1
CL2009001087A1 CL2009001087A CL2009001087A CL2009001087A1 CL 2009001087 A1 CL2009001087 A1 CL 2009001087A1 CL 2009001087 A CL2009001087 A CL 2009001087A CL 2009001087 A CL2009001087 A CL 2009001087A CL 2009001087 A1 CL2009001087 A1 CL 2009001087A1
Authority
CL
Chile
Prior art keywords
food product
carbohydrate mixture
type
equivalent
enteral
Prior art date
Application number
CL2009001087A
Other languages
English (en)
Inventor
Hernandez Angel San Roman Pais Paloma Y Perez Rodriguez Milagros Gil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41264457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009001087(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of CL2009001087A1 publication Critical patent/CL2009001087A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA MEZCLA DE HIDRATOS DE CARBONO Y A SU UTILIZACIÓN PARA LA PREPARACIÓN DE UN PRODUCTO ALIMENTICIO DESTINADO A LA ALIMENTACIÓN VÍA ORAL O ENTERAL, EN ESPECIAL PARA LA ALIMENTACIÓN DEL PACIENTE DIABÁTICO Y EN PARTICULAR PARA LA ALIMENTACIÓN DEL PACIENTE DE DIABETES DE TIPO II Y SU COMORBILIDAD ASOCIADA. LA MEZCLA DE HIDRATOS DE CARBONO DE LA PRESENTE INVENCIÓN ESTÁ CONSTITUIDA POR ALMIDÓN RESISTENTE DE TIPO IV O RS IV (MALTODEXTRINA MODIFICADA), MALTODEXTRINA DE BAJA DEXTROSA EQUIVALENTE DE = 5-8, PREFERENTEMENTE DE IGUAL A 6, INULINA Y CELULOSA Y ESTÁ EXENTA DE FRUCTOSA.
CL2009001087A 2008-05-07 2009-05-06 Mezcla de hidratos de carbono para su utilizacion en un producto alimenticio destinado a la nutricion enteral u oral que comprende almidon resistente de tipo iv, maltodextrina de baja dextrosa equivalente de=5-8, inulina y celulosa; producto alimenticio que la contiene; y uso de la mezcla de hidratos de carbono. CL2009001087A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2008/000319 WO2009135960A1 (es) 2008-05-07 2008-05-07 Mezcla de hidratos de carbono y su utilización para preparar un producto destinado a la alimentación oral o enteral

Publications (1)

Publication Number Publication Date
CL2009001087A1 true CL2009001087A1 (es) 2010-10-01

Family

ID=41264457

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001087A CL2009001087A1 (es) 2008-05-07 2009-05-06 Mezcla de hidratos de carbono para su utilizacion en un producto alimenticio destinado a la nutricion enteral u oral que comprende almidon resistente de tipo iv, maltodextrina de baja dextrosa equivalente de=5-8, inulina y celulosa; producto alimenticio que la contiene; y uso de la mezcla de hidratos de carbono.

Country Status (6)

Country Link
US (1) US20110053888A1 (es)
EP (1) EP2294932B1 (es)
CL (1) CL2009001087A1 (es)
ES (1) ES2583602T3 (es)
PT (1) PT2294932E (es)
WO (1) WO2009135960A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6104647B2 (ja) * 2013-03-07 2017-03-29 三栄源エフ・エフ・アイ株式会社 半固形化流動食又は栄養剤
CZ2015564A3 (cs) * 2015-08-20 2017-01-18 Vysoká škola chemicko-technologická v Praze Kompozice s vyšším obsahem rezistentního škrobu na bázi chemické a extruzní modifikace škrobu
CN111084384A (zh) * 2019-12-30 2020-05-01 湖南点道生物科技有限公司 一种复合碳水化合物组件及其制备方法
CN111154818B (zh) * 2020-01-17 2022-03-15 江南大学 一种直链糊精的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358729A (en) * 1991-08-28 1994-10-25 Matsutani Chemical Industries Co., Ltd. Indigestible dextrin
NZ250048A (en) * 1992-10-28 1994-10-26 Enzyme Bio Systems Ltd Production of maltodextrins by selective hydrolysation of starches by enzymatic methods
DE69506095T2 (de) * 1995-08-04 1999-06-24 Naamloze Vennootschap Nutricia, Zoetermeer Diätfasern enthaltende Nahrungszusammensetzung
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
ES2206821T3 (es) 1997-06-23 2004-05-16 Societe Des Produits Nestle S.A. Uso de una composicion nutritiva para la preparacion de una composicion liquida para diabeticos.
DE10214327A1 (de) 2001-10-23 2003-05-22 Innogel Ag Zug Netzwerk auf Polysaccharidbasis und Verfahren zu dessen Herstellung
US20040087514A1 (en) 2002-09-06 2004-05-06 Hughes Thomas E Nutritional compositions
AU2004281184C1 (en) * 2003-10-16 2012-01-12 Techcom Group, Llc Reduced digestible carbohydrate food having reduced blood glucose response
SE0400355D0 (sv) 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
US20060025381A1 (en) * 2004-07-29 2006-02-02 National Starch And Chemical Investment Holding Company Use of a chemically modified starch product
US20060068073A1 (en) 2004-09-28 2006-03-30 Catani Steven J Low calorie, palatable sugar substitute with water insoluble bulking agent
US20060093720A1 (en) 2004-10-28 2006-05-04 Ed Tatz Pumpable, semi-solid low calorie sugar substitute compositions
CN101175416A (zh) * 2005-04-06 2008-05-07 诺瓦提斯公司 从营养方面改善葡萄糖控制和胰岛素作用的方法和组合物
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
WO2007004883A2 (en) 2005-07-05 2007-01-11 N.V. Nutricia A carbohydrate fraction and use thereof for a flat postprandial glucose response
CA2629014A1 (en) * 2005-12-13 2007-06-21 Archer-Daniels-Midland Company Food products, methods of producing thes food products, and methods of distributing the food products and ingredients thereof

Also Published As

Publication number Publication date
WO2009135960A1 (es) 2009-11-12
EP2294932A1 (en) 2011-03-16
PT2294932E (pt) 2016-02-03
EP2294932B1 (en) 2015-10-21
ES2583602T3 (es) 2016-09-21
EP2294932A4 (en) 2014-08-27
US20110053888A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
MX390994B (es) Composicion nutricional que contiene mezcla de oligosacaridos.
MX2016006577A (es) Uso de composiciones nutritivas que tienen una cantidad baja de proteina.
CO6781465A2 (es) Composición farmacéutica, métodos de tratamiento y usos de la misma
BR112016027851A2 (pt) composições de fibra e de carboidrato, produto alimentício, métodos de produção de composição, de redução do índice glicêmico e de inibição da elevação do nível de açúcar, composição de baixa cariogenicidade e uso da composição
AR089835A1 (es) Jarabes reducidos en azucar y metodos para preparar jarabes reducidos en azucar
CL2012003197A1 (es) Formulación farmacéutica acuosa que comprende 200-1000 u/ml de insulina glargina, con condición de que la concentración de dicha formulación no sea 684 u/ml de insulina glargina; y su uso para tratar diabetes mellitus de tipo i y tipo ii en un paciente.
CL2013000716A1 (es) Un profarmaco o una sal del mismo que comprende un conjugado de exendina-conector; procedimiento de preparacion de dicho profarmaco; compuestos intermediarios; composicion farmaceutica que lo comprende, util para mejorar el control glucemico en pacientes con diabetes de tipo 2.
AR050130A1 (es) Reemplazo funcional de azucar
BR112016027839A2 (pt) composições de fibra e de carboidrato, produto alimentício, métodos de produção de composição de fibra, de elaboração de composição de carboidrato misturada, de redução do índice glicêmico de alimentos ou bebidas e de inibição da elevação do nível de açúcar no sangue, composição cosmética, uso da composição de fibra e produto
CL2009000018A1 (es) Analogo de la insulina con tiempo de accion plano y prolongado; procedimiento de preparación; uso para tratar diabetes mellitus; producto farmaceutico y formulacion que lo comprende; secuencia nucleotidica que lo codifica; vector; y célula hospedera.
CL2008002486A1 (es) Comprimido divisible de liberacion modificada que comprende glicazida, un derivado de celulosa elegido entre: hmc, hec, hpc y/o hpmc y un aglutinante elegido entre: maltodextrina, polividona o hpmc; uso para tratar diabetes.
UY31205A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
BRPI0808979B8 (pt) preparação, seu uso, e usos de butanol
PA8846101A1 (es) Anticuerpos del receptor ii anti-tgf-beta
BRPI0908541B8 (pt) uso de panax quinquefolius ou uma fração do mesmo na ativação de respostas imunes inatas e adaptativas
CL2013003003A1 (es) Uso de fórmula infantil que comprende al menos una fuente de proteínas, una fuente de lípidos, una fuente de carbohidratos, con 1,6-1,85 g/100 kcal que sirve para preparar un medicamento útil en la prevención de la presión sanguínea elevada o de las enfermedades cardiovasculares.
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
BR112013015634B8 (pt) composição que compreende gordura, proteína e carboidratos, uso da composição, uso de fibras alimentares, processo para preparação de uma fórmula infantil e processo para preparação da composição
BR112015029911A2 (pt) bolo alimentar líquido coesivo compreendendo moléculas que fornecem viscoelasticidade
AR056313A1 (es) Inulina de cadena larga
BR112013016590A2 (pt) uso de estabilizantes de glutamina
Zhao et al. Advanced development in analysis of phytochemicals from medicine and food dual purposes plants used in China
AR063891A1 (es) Composicion para ser usada en productos alimenticios, preparados nutricionales, nutraceuticos y farmaceuticos
ES2583602T3 (es) Mezcla de hidratos de carbono y su utilización para preparar un producto destinado a la alimentación oral o enteral